China Biotech Services Holdings (HKSE:08037) FCF Yield % : 39.25 (As of Jun. 06, 2024)

View and export this data going back to 2004. Start your Free Trial

What is China Biotech Services Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, China Biotech Services Holdings's Trailing 12-Month Free Cash Flow is HK$132.3 Mil, and Market Cap is HK$337.1 Mil. Therefore, China Biotech Services Holdings's FCF Yield % for today is 39.25%.

The historical rank and industry rank for China Biotech Services Holdings's FCF Yield % or its related term are showing as below:

HKSE:08037' s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 131.93
Current: 39.25

During the past 13 years, the highest FCF Yield % of China Biotech Services Holdings was 131.93%. The lowest was 0.00%. And the median was 0.00%.

HKSE:08037's FCF Yield % is ranked better than
98.7% of 231 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.14 vs HKSE:08037: 39.25

China Biotech Services Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

China Biotech Services Holdings FCF Yield % Historical Data

The historical data trend for China Biotech Services Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Biotech Services Holdings FCF Yield % Chart

China Biotech Services Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.03

23.50

2.13

32.61

17.84

China Biotech Services Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of China Biotech Services Holdings's FCF Yield %

For the Diagnostics & Research subindustry, China Biotech Services Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Biotech Services Holdings's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Biotech Services Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where China Biotech Services Holdings's FCF Yield % falls into.

China Biotech Services Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

China Biotech Services Holdings's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	132.309	/	741.68787
	=	17.84%

China Biotech Services Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	741.68787
	=	0.00%

China Biotech Services Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

China Biotech Services Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of China Biotech Services Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Biotech Services Holdings (HKSE:08037) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Biotech Services Holdings Ltd (HKSE:08037) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG

Website

http://www.cbshhk.com

China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.

Executives

Liu Xiaolin	2101 Beneficial owner
Genius Earn Limited	2201 Interest of corporation controlled by you
Genius Lead Limited	2101 Beneficial owner
Guoyuan International Holdings Limited	2201 Interest of corporation controlled by you
Guoyuan Securities Co., Ltd.	2201 Interest of corporation controlled by you
Guoyuan Securities Investment (hong Kong) Limited	2101 Beneficial owner
Richlane Ventures Limited	2101 Beneficial owner
Ko Chun Shun, Johnson	2201 Interest of corporation controlled by you

China Biotech Services Holdings (HKSE:08037) Headlines

No Headlines